Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myeloid, Acute 3Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Leukemia 2Waldenstrom Macroglobulinemia 1Neurologic Manifestations 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma 1Leukemia, Prolymphocytic 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Graft vs Host Disease 1Chromosome 17 deletion 1Cardiovascular Diseases 1COVID-19 1Breast Neoplasms 1

Interventions

Cyclophosphamide 43Tacrolimus 39Methotrexate 30Cyclosporine 28Mycophenolic Acid 25fludarabine phosphate 22Antilymphocyte Serum 22Melphalan 20Busulfan 20Sirolimus 18Methylprednisolone 18Radiotherapy 17Peripheral Blood Stem Cell Transplantation 17fludarabine 15Whole-Body Irradiation 15Filgrastim 14Thiotepa 8Rituximab 8thymoglobulin 7Etoposide 7Granulocyte Colony-Stimulating Factor 6Cord Blood Stem Cell Transplantation 6Transplantation 5Therapeutics 5Stem Cell Transplantation 5Prednisone 5Flow Cytometry 5Cyclosporins 5Alemtuzumab 5ruxolitinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × Atorvastatin × Lymphoid × Clear all
NCT03066466 2021-04-27

Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT

Loyola University

Phase 3 Withdrawn
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡